Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Trauma and Emergency Surgery

02-05-2024 | Chronic Inflammatory Bowel Disease | Original Article

Management of inflammatory bowel disease in the emergency setting: the MIBODI international survey and evidence-based practices

Authors: Belinda De Simone, Justin Davies, Fikri M. Abu-Zidan, Massimo Sartelli, Gianluca Pellino, Genevieve Deeken, Walter L. Biffl, Nicola De’Angelis, Ernest E. Moore, Raul Coimbra, MIBODI Collaborative group, Fausto Catena

Published in: European Journal of Trauma and Emergency Surgery

Login to get access

Abstract

Aim

This study aimed to evaluate the impact of the WSES-AAST guidelines in clinical practice and to investigate the knowledge, attitudes, and practices of emergency surgeons in managing the complications of ulcerative colitis (UC) and Crohn’s disease (CD).

Methods

The MIBODI survey is a cross-sectional study among WSES members designed as an international web-based survey, according to the Checklist for Reporting Results of Internet E-Surveys, to collect data on emergency surgeons’ knowledge, attitudes, and practices concerning the management of patients presenting with acute complications of CD and UC. The questionnaire was composed of 30 questions divided into five sections: (1) demographic data, (2) primary evaluation, (3) non-operative management, (4) operative management, and (5) perianal sepsis management.

Results

Two hundred and forty-two surgeons from 48 countries agreed to participate in the survey. The response rate was 24.2% (242/1000 members on WSES mail list).
Emergency surgeons showed high adherence to recommendations for 6 of the 21 assessed items, with a “correct” response rate greater than or equal to 60%, according to WSES-AAST recommendations. Nine critical issues were highlighted, with correct answers at a rate of less than 50%.

Conclusions

Inflammatory bowel disease is a complex disease that requires a multidisciplinary approach with close collaboration between gastroenterologists and surgeons. Emergency surgeons play a crucial role in managing complications related to IBD. One year after publication, the MIBODI study showed significant global implementation of the WSES-AAST guidelines in clinical practice, offering an imperative tool in the improved management of IBD in emergency and urgent settings.
Appendix
Available only for authorised users
Literature
1.
2.
Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.CrossRefPubMed
3.
4.
5.
6.
7.
8.
9.
Hulley SB, Newman TB, Cummings SR. Choosing the study subjects: specification, sampling and recruitment. In: Hulley SB, Cummings SR, Browner WS, Grady DG, Newman TB. Designing clinical research. 3rd edition, Lippincott Williams & Wilkins, PA, USA. 2007.
10.
11.
12.
13.
14.
15.
16.
Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol. 2007;5:103–10.CrossRefPubMed
17.
18.
Henriksen M, Jahnsen J, Lygren I, et al. Surgical treatment for complications of Crohn’s disease in a population-based cohort. Scand J Gastroenterol. 2013;48(5):507–13.
19.
Lightner AL, Pemberton JH, Loftus EV Jr, et al. Emergency surgery for ulcerative colitis: outcomes and predictors of colectomy. J Gastrointest Surg. 2017;21(11):1852–62.
20.
Khanna S, Shin A, Kelly CP. Management of Clostridium difficile infection in inflammatory bowel disease: expert review from the clinical practice updates committee of the AGA institute. Clin Gastroenterol Hepatol. 2017;15:166–74.CrossRefPubMed
21.
Rodemann JF, Dubberke ER, Reske KA, Seo DH, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339–44.CrossRefPubMed
22.
Groof EJ, Carbonnel F, Buskens CJ, Bemelman WA. Abdominal abscess in Crohn’s disease: multidisciplinary management. Dig Dis. 2014;32(Suppl 1):103–9.CrossRefPubMed
23.
Khan KJ, Ullman TA, Ford AC, et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011;106:661–73.CrossRefPubMed
24.
25.
26.
27.
28.
Pineton de Chambrun G, et al. 457 Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: long-term results of the MICA study. Gastroenterology. 2021;160(Suppl 6):S92.CrossRef
29.
Shehab M, Alrashed F, Heron V, Restellini S, Bessissow T. Comparative efficacy of biologic therapies for inducing response and remission in fistulizing Crohn’s disease: systematic review and network meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2023;29(3):367–75. https://​doi.​org/​10.​1093/​ibd/​izac103.CrossRefPubMed
30.
Turner D, Walsh CM, Steinhart AH, et al. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol. 2007;5:103–10.CrossRefPubMed
31.
Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, et al. Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. Lancet. 2012;380(9857):1909–15.CrossRefPubMed
32.
Cohen B, Fleshner P, Kane S. Anti-tumor necrosis factor is not associated with postoperative infections: results from prospective cohort of ulcerative colitis and Crohn’s disease patients undergoing surgery to identify risk factors for postoperative infections (PUCCINI). Gastroenterology. 2019;156:S-80.CrossRef
33.
Lan N, Shen B. Endoscopic stricturotomy versus balloon dilation in the treatment of anastomotic strictures in Crohn’s disease. Inflamm Bowel Dis. 2018;24:897–907.CrossRefPubMed
34.
35.
36.
37.
38.
Sachar DB, Wolfson DM, Greenstein AJ, et al. Risk factors for postoperative recurrence of Crohn’s disease. Middle East J Digest Dis. 2012;4:199.
39.
40.
41.
Kono T, Fichera A, Maeda K, et al. Kono-S anastomosis for surgical prophylaxis of anastomotic recurrence in Crohn’s disease: an international multicenter study. J Gastrointest Surg. 2016;20:783–90.CrossRefPubMed
42.
43.
Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med. 2004;350(09):876–85.CrossRefPubMed
44.
Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn’s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis. 2003;9:98–103.CrossRefPubMed
45.
Newton K, Dumville J, Briggs M, Law J, Martin J, Pearce L, Kirwan C, Pinkney T, Needham A, Jackson R, Winn S, McCulloch H, Hill J; PPAC2 Collaborators. Postoperative packing of perianal abscess cavities (PPAC2): randomized clinical trial. Br J Surg. 2022;109(10):951–957. https://​doi.​org/​10.​1093/​bjs/​znac225
46.
47.
48.
Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:345–51.CrossRefPubMed
49.
50.
Feagins LA, Holubar SD, Kane SV, Spechler SJ. Current strategies in the management of intra-abdominal abscesses in Crohn’s disease. Clin Gastroenterol Hepatol. 2011;9:842–50.CrossRefPubMed
51.
52.
53.
54.
55.
Lan N, Shen B. Endoscopic stricturotomy with needle knife in the treatment of strictures from inflammatory bowel disease. Inflamm Bowel Dis. 2017;23:502–13.CrossRefPubMed
56.
57.
Metadata
Title
Management of inflammatory bowel disease in the emergency setting: the MIBODI international survey and evidence-based practices
Authors
Belinda De Simone
Justin Davies
Fikri M. Abu-Zidan
Massimo Sartelli
Gianluca Pellino
Genevieve Deeken
Walter L. Biffl
Nicola De’Angelis
Ernest E. Moore
Raul Coimbra
MIBODI Collaborative group
Fausto Catena
Publication date
02-05-2024
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Trauma and Emergency Surgery
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-024-02526-7